PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
05-May-2023 Lonza Announces Results of the 2023 Annual General Meeting – All Motions Proposed by Board of Directors Accepted Lonza Group AG
05-May-2023 Amolyt Pharma Announces Abstracts Accepted for Presentation at ECE and ENDO Amolyt Pharma
05-May-2023 Heidelberg Pharma appoints Chief Financial Officer Heidelberg Pharma AG
05-May-2023 Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio Transgene
05-May-2023 Kinarus Therapeutics Reports Key Unaudited Full Year 2022 Figures Kinarus Therapeutics Holding AG
05-May-2023 Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026 Evolva Holding SA
04-May-2023 Annual General Meeting 2023: Zur Rose Group AG to be renamed DocMorris AG (stock exchange ticker symbol DOCM) Zur Rose Group AG
04-May-2023 Neuraxpharm rebrands Laboratorios Lesvi as Neuraxpharm Pharmaceuticals S.L. Neuraxpharm Group (Neuraxpharm),
04-May-2023 4.2 million of us have undiagnosed high blood pressure. Make testing universal, urges specialist. London Medical Laboratory
04-May-2023 Abivax publishes Universal Registration Document 2023 “Document d’Enregistrement Universel” ABIVAX
04-May-2023 PM Society Securing Market Access to Medicines for the UK & Ireland – The Landscape Ahead
04-May-2023 Nouscom Reaches Clinical Phase II Using ProBioGen’s AGE1.CR.pIX® Production Platform B3C newswire
04-May-2023 MediClin AG: Encouraging development of Group sales in the first quarter of 2023 MediClin AG
04-May-2023 Zur Rose Group has successfully completed the sale of its Swiss business to Migros Zur Rose Group AG
04-May-2023 MediClin AG: Mercurius Health acquires Robert Janker Klinik in Bonn, Germany, previously owned by MEDICLIN MediClin AG
04-May-2023 Biotest AG: Biotest’s Hyperimmunoglobulin Cytotect® CP receives five additional Marketing Authorisations in Europe Biotest AG
03-May-2023 MorphoSys AG Reports First Quarter 2023 Financial Results MorphoSys AG
03-May-2023 Medacta showcases NextAR Spine MIS LT procedure at Spine Week, efficiently complementing operative workflow for spine surgery Medacta Group SA
03-May-2023 Annual General Meeting of SKAN Group AG approves all proposals SKAN AG
03-May-2023 Bloomsbury Genetic Therapies Receives Rare Paediatric Disease Designation from the U.S. FDA for BGT-DTDS for the Treatment of Dopamine Transporter Deficiency Syndrome (DTDS) Bloomsbury Genetic Therapies Limited